These 8 leaders from our campus recently completed the Executive Leadership Institute, sponsored by the UT System. I appreciate their interest in learning more about leadership and I value the UT System’s commitment to leadership development. #leadershipmatters
Training completed for the Cor-Cinch clinical trial:
HFrEF 20% - 40%
Class 3 / ambulatory 4
Class 2 if hospitalized in the last year
LVEDD > 5.5 cm
MR 2+ or less (post TEER included)
Happy to see any possible candidate!
CT/FFR has improved diagnostic accuracy when evaluating chest pain patients for coronary artery disease. Outstanding correlation with IVUS/FFR in the cath lab. Will not replace SPECT or stress echo (due to limitations), but it is a fantastic tool.
@IRKhalsa@XLR8Med Celt is a breakthrough, possibly the best small bore VCD. We trialed it a couple of years ago. Still trying to get it on the shelf. Celt is complementary to Perclose and Angioseal.
88 yo with abdominal pain, hematochezia and weight loss. Risk factors of HTN, Chol. Hx of CABG. Abdom. CTA showed densely calcified plaque. C-scope confirmed colitis. Stented the SMA, resolving 60 mmHg gradient. What next?